…remission and mucosal healing by September 2024, at which point mesalamine was discontinued. Concomitantly, at diagnosis, blood tests show…
4articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Mesalamine ×
Mesalamine
This drug is selected. Its supporting articles are shown below.
Articles mentioning Mesalamine
4 articles · page 1 of 1mesalamine5-ASAulcerative colitisCrohn’s diseasetubulointerstitial nephritisamyloidosisnephrolithiasisglomerulonephritisGranulomatous interstitial nephritisIBDU
rifaximinmesalamineUniversity of California San DiegoUniversity of PennsylvaniaStanford UniversityUT Health Lyndon B. Johnson HospitalAlbany Medical CollegeUniversity of California San FranciscoNew York-Presbyterian Queens
…lected from options including fibre, probiotics, mesalamine and rifaximin). A total of 100 patients who decline randomisation but consent…
Mesalamine5-ASAulcerative colitisCRCLynch syndromecolorectal cancerSwedish Research CouncilEuropean Clinical Trials Information SystemLScolorectal neoplasia+1 more
…f colorectal cancer (CRC) due to mismatch repair gene variants. Mesalamine (5-ASA, 5-aminosalicylic acid), used safely in patients with ul…
mesalamineFaecal calprotectinCrohn’s disease
…; reference: ≤50 mg/kg), and the patient was put on a course of mesalamine, for a clinical diagnosis of Crohn’s disease.…